Merck & Co., Inc. Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31)
Merck & Co., Inc. (MRK) had Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) of $3.00 billion as of 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards › Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement
us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateBenefitObligation · last filed 2014-02-27
- 2013-12-31: Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) $3.00B.
- 2012-12-31: Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) $15.50B.
- 2011-12-31: Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) $11.90B.
- 2010-12-31: Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) $6.40B.
| Period end | Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) |
|---|---|
| 2013-12-31 | $3.00B 10-K · filed 2014-02-27 |
| 2012-12-31 | $15.50B 10-K · filed 2014-02-27 |
| 2011-12-31 | $11.90B 10-K · filed 2013-02-28 |
| 2010-12-31 | $6.40B 10-K · filed 2012-02-28 |
| 2009-12-31 | $7.70B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |